首頁 › 肥胖症 › 德克薩斯州 › Grand Prairie
Grand Prairie, TX 的 肥胖症 臨床試驗
13 項針對 肥胖症 的研究正在 Grand Prairie（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Epic Medical Research - Red Oak, DeSoto · 距離 14 英里
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
招募中3 期
- Epic Medical Research, DeSoto · 距離 14 英里
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
招募中3 期
- Epic Medical Research - DeSoto, DeSoto · 距離 14 英里
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
招募中3 期
- Research Site, DeSoto · 距離 14 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, DeSoto · 距離 14 英里
- AURORA-2 Clinical Site, Waxahachie · 距離 26 英里
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- Dallas Heart and Vascular Consultants, Duncanville · 距離 8 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, DeSoto · 距離 14 英里
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Epic Medical Research, DeSoto · 距離 14 英里
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
招募中3 期
- Epic Medical Research, DeSoto · 距離 14 英里
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
招募中3 期
- Kailera Clinical Site, DeSoto · 距離 14 英里
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
招募中3 期
- Kailera Clinical Site, DeSoto · 距離 14 英里
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
招募中3 期
- Epic Medical Research - DeSoto, DeSoto · 距離 14 英里
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
招募中3 期
- Dallas Heart and Vascular, Duncanville · 距離 8 英里
其他城市的 肥胖症 試驗
- Houston, TX43 項研究
- Chicago, IL41 項研究
- New York City, NY40 項研究
- San Antonio, TX40 項研究
- Washington, DC33 項研究
- Orlando, FL32 項研究
- Dallas, TX30 項研究
- Boston, MA28 項研究
- Las Vegas, NV27 項研究
- Miami, FL27 項研究
- Baltimore, MD26 項研究
- Jacksonville, FL25 項研究
Grand Prairie 的其他研究
- 過重11 項研究
- 重度憂鬱症11 項研究
- 精神分裂症8 項研究
- 憂鬱症8 項研究
- 脂肪性肝病5 項研究
- 心臟衰竭4 項研究
- 慢性阻塞性肺病3 項研究
- 偏頭痛3 項研究
- 第二型糖尿病3 項研究
- 精神病性障礙3 項研究
- 情緒障礙3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。